These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 2094677)
41. Antituberculous agents. Van Scoy RE; Wilkowske CJ Mayo Clin Proc; 1987 Dec; 62(12):1129-36. PubMed ID: 3682957 [TBL] [Abstract][Full Text] [Related]
42. [Therapy of tuberculosis in the adult]. Schrappe M; Wassermann K; Kroegel C Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936 [No Abstract] [Full Text] [Related]
43. Neurotoxicity of antituberculous drugs in a patient without active tuberculosis. Leppert D; Waespe W Ital J Neurol Sci; 1988 Feb; 9(1):31-4. PubMed ID: 2833462 [TBL] [Abstract][Full Text] [Related]
47. Treatment of tuberculosis. McNicol M J R Coll Physicians Lond; 1979 Jan; 13(1):23-4. PubMed ID: 762670 [No Abstract] [Full Text] [Related]
48. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis]. Knop P; Kindler U; Merholz T Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308 [No Abstract] [Full Text] [Related]
49. Isoniazid therapy in relation to later occurrence of cancer in adults and in infants. Hammond EC; Selikoff IJ; Robitzek EH Br Med J; 1967 Jun; 2(5555):792-5. PubMed ID: 6029139 [No Abstract] [Full Text] [Related]
50. Teratology of the antituberculosis drugs. Holdiness MR Early Hum Dev; 1987 Mar; 15(2):61-74. PubMed ID: 3297625 [TBL] [Abstract][Full Text] [Related]
51. Pyridoxine in pregnant women receiving antituberculous drugs. Kittisupamongkol W BJOG; 2009 Aug; 116(9):1274; author reply 1274-5. PubMed ID: 19624445 [No Abstract] [Full Text] [Related]
52. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues. Skevaki CL; Kafetzis DA Paediatr Drugs; 2005; 7(4):219-34. PubMed ID: 16117559 [TBL] [Abstract][Full Text] [Related]
53. Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong. Chan TY Int J Clin Pharmacol Ther; 1996 Dec; 34(12):533-4. PubMed ID: 8996847 [TBL] [Abstract][Full Text] [Related]
54. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
55. [Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin]. Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H; Mohri M Kekkaku; 2003 Apr; 78(4):339-46. PubMed ID: 12739393 [TBL] [Abstract][Full Text] [Related]
57. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis. Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167 [No Abstract] [Full Text] [Related]